BIODESIX INC (BDSX)
US09075X1081 - Common Stock
Friday 11/22 Insider Buying Report: BDSX, KINS
Bargain Hunters Take Note: Insider Cluster-Buying At BDSX
Biodesix Announces Third Quarter 2024 Results and Highlights
Biodesix Announces Third Quarter 2024 Results and Highlights
Q3 2024 revenue grew 35% over Q3 2023 to $18.2 million; Q3 2024 gross profit margin of 77.0%, up from 76.1% in Q3 2023; Q3 2024 Net loss improved by 6%...
Biodesix to Participate in Three Investor Conferences in November
Biodesix to Participate in Three Investor Conferences in November
LOUISVILLE, Colo., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease,...
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
Biodesix to Present at Two Investor Conferences in September
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q2 2024
BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biodesix (NASDAQ:BDSX) just reported results for the second quarter of 2024.Bio...
Biodesix Announces Second Quarter 2024 Results and Highlights
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
Biodesix to Participate in Two Investor Conferences in June
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024
BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biodesix (NASDAQ:BDSX) just reported results for the first quarter of 2024.Biod...
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.